EMEA (Europe, Middle East and Africa) Organ Transplant Immunosuppressant Market Report 2017

August 2017 | 102 pages | ID: E197F9D0CFFEN
QYResearch

Abstracts

In this report, the EMEA Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Organ Transplant Immunosuppressant for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Organ Transplant Immunosuppressant market competition by top manufacturers/players, with Organ Transplant Immunosuppressant sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astellas Pharma
• Novartis
• Pfizer
• Sanofi
• AbbVie
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• AstraZeneca
• Bayer
• Johnson & Johnson

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Selective inhibitor of cytokine production and function
• Immunosuppressive antimetabolites
• Immunosuppressive antibodies
• Immunosuppressive adrenocorticosteroids

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Organ Transplant Immunosuppressant for each application, including

• Kidney transplantation
• Liver transplantation
• Heart transplantation
• Lung transplantation
• Pancreas transplantation

Contents

EMEA (Europe, Middle East and Africa) Organ Transplant Immunosuppressant Market Report 2017

1 ORGAN TRANSPLANT IMMUNOSUPPRESSANT OVERVIEW

1.1 Product Overview and Scope of Organ Transplant Immunosuppressant
1.2 Classification of Organ Transplant Immunosuppressant
  1.2.1 EMEA Organ Transplant Immunosuppressant Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Organ Transplant Immunosuppressant Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Selective inhibitor of cytokine production and function
  1.2.4 Immunosuppressive antimetabolites
  1.2.5 Immunosuppressive antibodies
  1.2.6 Immunosuppressive adrenocorticosteroids
1.3 EMEA Organ Transplant Immunosuppressant Market by Application/End Users
  1.3.1 EMEA Organ Transplant Immunosuppressant Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Kidney transplantation
  1.3.3 Liver transplantation
  1.3.4 Heart transplantation
  1.3.5 Lung transplantation
  1.3.6 Pancreas transplantation
1.4 EMEA Organ Transplant Immunosuppressant Market by Region
  1.4.1 EMEA Organ Transplant Immunosuppressant Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Organ Transplant Immunosuppressant (2012-2022)
  1.5.1 EMEA Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Organ Transplant Immunosuppressant Revenue and Growth Rate (2012-2022)

2 EMEA ORGAN TRANSPLANT IMMUNOSUPPRESSANT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Organ Transplant Immunosuppressant Market Competition by Players/Manufacturers
  2.1.1 EMEA Organ Transplant Immunosuppressant Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Organ Transplant Immunosuppressant Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Organ Transplant Immunosuppressant Sale Price by Players (2012-2017)
2.2 EMEA Organ Transplant Immunosuppressant (Volume and Value) by Type/Product Category
  2.2.1 EMEA Organ Transplant Immunosuppressant Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Organ Transplant Immunosuppressant Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Organ Transplant Immunosuppressant Sale Price by Type (2012-2017)
2.3 EMEA Organ Transplant Immunosuppressant (Volume) by Application
2.4 EMEA Organ Transplant Immunosuppressant (Volume and Value) by Region
  2.4.1 EMEA Organ Transplant Immunosuppressant Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Organ Transplant Immunosuppressant Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Organ Transplant Immunosuppressant Sales Price by Region (2012-2017)

3 EUROPE ORGAN TRANSPLANT IMMUNOSUPPRESSANT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Organ Transplant Immunosuppressant Sales and Value (2012-2017)
  3.1.1 Europe Organ Transplant Immunosuppressant Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Organ Transplant Immunosuppressant Revenue and Growth Rate (2012-2017)
3.2 Europe Organ Transplant Immunosuppressant Sales and Market Share by Type
3.3 Europe Organ Transplant Immunosuppressant Sales and Market Share by Application
3.4 Europe Organ Transplant Immunosuppressant Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Organ Transplant Immunosuppressant Sales Volume by Countries (2012-2017)
  3.4.2 Europe Organ Transplant Immunosuppressant Revenue by Countries (2012-2017)
  3.4.3 Germany Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  3.4.4 France Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  3.4.5 UK Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  3.4.6 Russia Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  3.4.7 Italy Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ORGAN TRANSPLANT IMMUNOSUPPRESSANT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Organ Transplant Immunosuppressant Sales and Value (2012-2017)
  4.1.1 Middle East Organ Transplant Immunosuppressant Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Organ Transplant Immunosuppressant Revenue and Growth Rate (2012-2017)
4.2 Middle East Organ Transplant Immunosuppressant Sales and Market Share by Type
4.3 Middle East Organ Transplant Immunosuppressant Sales and Market Share by Application
4.4 Middle East Organ Transplant Immunosuppressant Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Organ Transplant Immunosuppressant Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Organ Transplant Immunosuppressant Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  4.4.4 Israel Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  4.4.5 UAE Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  4.4.6 Iran Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)

5 AFRICA ORGAN TRANSPLANT IMMUNOSUPPRESSANT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Organ Transplant Immunosuppressant Sales and Value (2012-2017)
  5.1.1 Africa Organ Transplant Immunosuppressant Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Organ Transplant Immunosuppressant Revenue and Growth Rate (2012-2017)
5.2 Africa Organ Transplant Immunosuppressant Sales and Market Share by Type
5.3 Africa Organ Transplant Immunosuppressant Sales and Market Share by Application
5.4 Africa Organ Transplant Immunosuppressant Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Organ Transplant Immunosuppressant Sales Volume by Countries (2012-2017)
  5.4.2 Africa Organ Transplant Immunosuppressant Revenue by Countries (2012-2017)
  5.4.3 South Africa Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Organ Transplant Immunosuppressant Sales and Growth Rate (2012-2017)

6 EMEA ORGAN TRANSPLANT IMMUNOSUPPRESSANT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Astellas Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Pharma Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AbbVie
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AbbVie Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 F. Hoffmann-La Roche
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 F. Hoffmann-La Roche Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 AstraZeneca
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 AstraZeneca Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bayer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bayer Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Organ Transplant Immunosuppressant Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 ORGAN TRANSPLANT IMMUNOSUPPRESSANT MANUFACTURING COST ANALYSIS

7.1 Organ Transplant Immunosuppressant Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Organ Transplant Immunosuppressant Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Organ Transplant Immunosuppressant Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ORGAN TRANSPLANT IMMUNOSUPPRESSANT MARKET FORECAST (2017-2022)

11.1 EMEA Organ Transplant Immunosuppressant Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Organ Transplant Immunosuppressant Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Organ Transplant Immunosuppressant Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Organ Transplant Immunosuppressant Price and Trend Forecast (2017-2022)
11.2 EMEA Organ Transplant Immunosuppressant Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Organ Transplant Immunosuppressant Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Organ Transplant Immunosuppressant Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Organ Transplant Immunosuppressant Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Organ Transplant Immunosuppressant Sales Forecast by Type (2017-2022)
11.7 EMEA Organ Transplant Immunosuppressant Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Organ Transplant Immunosuppressant
Figure EMEA Organ Transplant Immunosuppressant Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Organ Transplant Immunosuppressant Sales Volume Market Share by Type (Product Category) in 2016
Figure Selective inhibitor of cytokine production and function Product Picture
Figure Immunosuppressive antimetabolites Product Picture
Figure Immunosuppressive antibodies Product Picture
Figure Immunosuppressive adrenocorticosteroids Product Picture
Figure EMEA Organ Transplant Immunosuppressant Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Organ Transplant Immunosuppressant by Application in 2016
Figure Kidney transplantation Examples
Figure Liver transplantation Examples
Figure Heart transplantation Examples
Figure Lung transplantation Examples
Figure Pancreas transplantation Examples
Figure EMEA Organ Transplant Immunosuppressant Market Size (Million USD) by Region (2012-2022)
Figure Europe Organ Transplant Immunosuppressant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Organ Transplant Immunosuppressant Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Organ Transplant Immunosuppressant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Organ Transplant Immunosuppressant Revenue (Million USD) Status and Forecast by Countries
Figure Africa Organ Transplant Immunosuppressant Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Organ Transplant Immunosuppressant Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Organ Transplant Immunosuppressant Sales Volume and Growth Rate (2012-2022)
Figure EMEA Organ Transplant Immunosuppressant Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Organ Transplant Immunosuppressant Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales Share by Players (2012-2017)
Figure 2016 Organ Transplant Immunosuppressant Sales Share by Players
Figure 2017 Organ Transplant Immunosuppressant Sales Share by Players
Figure EMEA Organ Transplant Immunosuppressant Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Revenue (Million USD) by Players (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Revenue Share by Players (2012-2017)
Table 2016 EMEA Organ Transplant Immunosuppressant Revenue Share by Players
Table 2017 EMEA Organ Transplant Immunosuppressant Revenue Share by Players
Table EMEA Organ Transplant Immunosuppressant Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales Share by Type (2012-2017)
Figure Sales Market Share of Organ Transplant Immunosuppressant by Type (2012-2017)
Figure EMEA Organ Transplant Immunosuppressant Sales Market Share by Type (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Organ Transplant Immunosuppressant by Type in 2016
Table EMEA Organ Transplant Immunosuppressant Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales Share by Application (2012-2017)
Figure Sales Market Share of Organ Transplant Immunosuppressant by Application (2012-2017)
Figure EMEA Organ Transplant Immunosuppressant Sales Market Share by Application in 2016
Table EMEA Organ Transplant Immunosuppressant Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Sales Share by Region (2012-2017)
Figure Sales Market Share of Organ Transplant Immunosuppressant by Region (2012-2017)
Figure EMEA Organ Transplant Immunosuppressant Sales Market Share in 2016
Table EMEA Organ Transplant Immunosuppressant Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Organ Transplant Immunosuppressant Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Organ Transplant Immunosuppressant by Region (2012-2017)
Figure EMEA Organ Transplant Immunosuppressant Revenue Market Share Regions in 2016
Table EMEA Organ Transplant Immunosuppressant Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Revenue and Growth Rate (2012-2017)
Table Europe Organ Transplant Immunosuppressant Sales (K Units) by Type (2012-2017)
Table Europe Organ Transplant Immunosuppressant Market Share by Type (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Market Share by Type in 2016
Table Europe Organ Transplant Immunosuppressant Sales (K Units) by Application (2012-2017)
Table Europe Organ Transplant Immunosuppressant Market Share by Application (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Market Share by Application in 2016
Table Europe Organ Transplant Immunosuppressant Sales (K Units) by Countries (2012-2017)
Table Europe Organ Transplant Immunosuppressant Sales Market Share by Countries (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Sales Market Share by Countries (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Sales Market Share by Countries in 2016
Table Europe Organ Transplant Immunosuppressant Revenue (Million USD) by Countries (2012-2017)
Table Europe Organ Transplant Immunosuppressant Revenue Market Share by Countries (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Revenue Market Share by Countries (2012-2017)
Figure Europe Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2016
Figure Germany Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure France Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure UK Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Organ Transplant Immunosuppressant Sales (K Units) by Type (2012-2017)
Table Middle East Organ Transplant Immunosuppressant Market Share by Type (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Market Share by Type (2012-2017)
Table Middle East Organ Transplant Immunosuppressant Sales (K Units) by Applications (2012-2017)
Table Middle East Organ Transplant Immunosuppressant Market Share by Applications (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Sales Market Share by Application in 2016
Table Middle East Organ Transplant Immunosuppressant Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Organ Transplant Immunosuppressant Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Sales Volume Market Share by Countries in 2016
Table Middle East Organ Transplant Immunosuppressant Revenue (Million USD) by Countries (2012-2017)
Table Middle East Organ Transplant Immunosuppressant Revenue Market Share by Countries (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Revenue Market Share by Countries (2012-2017)
Figure Middle East Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2016
Figure Saudi Arabia Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Organ Transplant Immunosuppressant Sales (K Units) by Type (2012-2017)
Table Africa Organ Transplant Immunosuppressant Sales Market Share by Type (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Sales Market Share by Type (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Sales Market Share by Type in 2016
Table Africa Organ Transplant Immunosuppressant Sales (K Units) by Application (2012-2017)
Table Africa Organ Transplant Immunosuppressant Sales Market Share by Application (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Sales Market Share by Application (2012-2017)
Table Africa Organ Transplant Immunosuppressant Sales Volume (K Units) by Countries (2012-2017)
Table Africa Organ Transplant Immunosuppressant Sales Market Share by Countries (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Sales Market Share by Countries (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Sales Market Share by Countries in 2016
Table Africa Organ Transplant Immunosuppressant Revenue (Million USD) by Countries (2012-2017)
Table Africa Organ Transplant Immunosuppressant Revenue Market Share by Countries (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Revenue Market Share by Countries (2012-2017)
Figure Africa Organ Transplant Immunosuppressant Revenue Market Share by Countries in 2016
Figure South Africa Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Table Astellas Pharma Organ Transplant Immunosuppressant Basic Information List
Table Astellas Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Astellas Pharma Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Novartis Organ Transplant Immunosuppressant Basic Information List
Table Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Novartis Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Pfizer Organ Transplant Immunosuppressant Basic Information List
Table Pfizer Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Pfizer Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Sanofi Organ Transplant Immunosuppressant Basic Information List
Table Sanofi Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Sanofi Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table AbbVie Organ Transplant Immunosuppressant Basic Information List
Table AbbVie Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AbbVie Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure AbbVie Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure AbbVie Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Organ Transplant Immunosuppressant Basic Information List
Table Bristol-Myers Squibb Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Organ Transplant Immunosuppressant Basic Information List
Table F. Hoffmann-La Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Organ Transplant Immunosuppressant Basic Information List
Table AstraZeneca Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Bayer Organ Transplant Immunosuppressant Basic Information List
Table Bayer Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Bayer Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Organ Transplant Immunosuppressant Basic Information List
Table Johnson & Johnson Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Organ Transplant Immunosuppressant Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Organ Transplant Immunosuppressant Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Organ Transplant Immunosuppressant
Figure Manufacturing Process Analysis of Organ Transplant Immunosuppressant
Figure Organ Transplant Immunosuppressant Industrial Chain Analysis
Table Raw Materials Sources of Organ Transplant Immunosuppressant Major Manufacturers in 2016
Table Major Buyers of Organ Transplant Immunosuppressant
Table Distributors/Traders List
Figure EMEA Organ Transplant Immunosuppressant Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Organ Transplant Immunosuppressant Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Organ Transplant Immunosuppressant Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Organ Transplant Immunosuppressant Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Organ Transplant Immunosuppressant Sales Market Share Forecast by Region (2017-2022)
Table EMEA Organ Transplant Immunosuppressant Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Organ Transplant Immunosuppressant Revenue Market Share Forecast by Region (2017-2022)
Table Europe Organ Transplant Immunosuppressant Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Organ Transplant Immunosuppressant Sales Market Share Forecast by Countries (2017-2022)
Table Europe Organ Transplant Immunosuppressant Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Organ Transplant Immunosuppressant Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Organ Transplant Immunosuppressant Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Organ Transplant Immunosuppressant Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Organ Transplant Immunosuppressant Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Organ Transplant Immunosuppressant Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Organ Transplant Immunosuppressant Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Organ Transplant Immunosuppressant Sales Market Share Forecast by Countries (2017-2022)
Table Africa Organ Transplant Immunosuppressant Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Organ Transplant Immunosuppressant Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Organ Transplant Immunosuppressant Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Organ Transplant Immunosuppressant Sales Market Share Forecast by Type (2017-2022)
Table EMEA Organ Transplant Immunosuppressant Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Organ Transplant Immunosuppressant Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources